1 week Colgate Advances 13% in a Year: To Buy or Not to Buy the Stock? Zacks
CL’s solid pricing strategies and premium innovation drive growth, but macroeconomic challenges and currency headwinds warrant cautious optimism.
XCL’s solid pricing strategies and premium innovation drive growth, but macroeconomic challenges and currency headwinds warrant cautious optimism.
X